LJPC logo

La Jolla Pharmaceutical (LJPC) Revenue

Annual Revenue

$75.72 M
+$42.30 M+126.58%

December 31, 2021

Summary

Performance

1-Year Change

+126.58%

3-Year Change

+652.98%

5-Year Change

-

15-Year Change

-

LJPC Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$75.72 M
LJPC annual revenue is currently at an all-time high

3-Year Low

$75.72 M
LJPC annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
LJPC previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
LJPC next annual earnings announcement has not yet been scheduled

OtherLJPCprofitabilitymetrics:

Annual EPS

$0.58
LJPC annual earnings per share is $0.58

Annual Net Income

$19.66 M
LJPC annual net profit is $19.66 million

Annual Operating Profit

$21.83 M
LJPC annual operating income is $21.83 million

Annual Gross Profit

$62.23 M
LJPC annual gross profit is $62.23 million

Quarterly Revenue

$10.54 M
+$118.00 K+1.13%

June 30, 2022

Summary

Performance

3-Month Change

+1.13%

1-Year Change

-34.35%

3-Year Change

+84.87%

5-Year Change

-

LJPC Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$34.14 M
LJPC quarterly revenue is currently -69.12% below its historical high of $34.14 million

3-Year Low

$10.43 M
LJPC quarterly revenue is currently +1.13% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
LJPC previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
LJPC next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$8.85 M
LJPC quarterly gross profit is $8.85 million

Quarterly Operating Profit

-$1.07 M
LJPC quarterly operating income is -$1.07 million

Quarterly Net Income

$2.46 M
LJPC quarterly net profit is $2.46 million

Quarterly EPS

$0.08
LJPC quarterly earnings per share is $0.08

TTM Revenue

$46.49 M
-$5.52 M-10.61%

June 30, 2022

Summary

Performance

3-Month Change

-10.61%

1-Year Change

-33.79%

3-Year Change

+101.67%

5-Year Change

+101.67%

LJPC TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$75.72 M
LJPC TTM revenue is currently -38.60% below its historical high of $75.72 million

3-Year Low

$46.49 M
LJPC TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
LJPC previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
LJPC next earnings announcement has not yet been scheduled

OtherLJPCprofitabilitymetrics:

TTM Gross Profit

$37.62 M
LJPC TTM gross profit is $37.62 million

TTM Operating Profit

-$2.57 M
LJPC TTM operating income is -$2.57 million

TTM Net Income

$3.97 M
LJPC TTM net profit is $3.97 million

TTM EPS

$0.12
LJPC TTM earnings per share is $0.12

LJPC Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+126.6%-34.4%-33.8%
3 y3 years+653.0%+84.9%+101.7%
5 y5 years--+101.7%

LJPC Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-13.7%-1.1%-38.6%at low
5 y5-yearat high-69.6%-69.1%-44.9%-38.6%-50.4%
alltimeall timeat high-100.0%-69.1%-100.1%-38.6%-100.0%

La Jolla Pharmaceutical Revenue History

DateAnnualQuarterlyTTM
Jun 2022
-
$10.54 M(+1.1%)
$46.49 M(-10.6%)
Mar 2022
-
$10.43 M(-14.6%)
$52.01 M(-31.3%)
Dec 2021
$75.72 M(+126.6%)
$12.21 M(-8.3%)
$75.72 M(+1.7%)
Sep 2021
-
$13.31 M(-17.1%)
$74.46 M(+6.0%)
Jun 2021
-
$16.06 M(-53.0%)
$70.22 M(+17.1%)
Mar 2021
-
$34.14 M(+211.7%)
$59.97 M(+79.4%)
Dec 2020
$33.42 M(+45.0%)
$10.95 M(+20.7%)
$33.42 M(+12.5%)
Sep 2020
-
$9.07 M(+56.3%)
$29.72 M(+12.8%)
Jun 2020
-
$5.80 M(-23.5%)
$26.35 M(+0.4%)
Mar 2020
-
$7.59 M(+4.7%)
$26.25 M(+13.9%)
Dec 2019
$23.05 M(+129.3%)
$7.25 M(+27.1%)
$23.05 M(+15.3%)
Sep 2019
-
$5.71 M(+0.1%)
$19.99 M(+12.6%)
Jun 2019
-
$5.70 M(+29.8%)
$17.75 M(+30.1%)
Mar 2019
-
$4.39 M(+5.0%)
$13.64 M(+35.7%)
Dec 2018
$10.06 M(+1532.5%)
$4.18 M(+20.6%)
$10.06 M(+71.3%)
Sep 2018
-
$3.47 M(+117.8%)
$5.87 M(+144.5%)
Jun 2018
-
$1.59 M(+96.9%)
$2.40 M(+196.9%)
Mar 2018
-
$809.00 K(+851.8%)
$809.00 K(+31.3%)
Dec 2016
$616.00 K(-41.7%)
$85.00 K(+93.2%)
$616.00 K(-34.5%)
Sep 2016
-
$44.00 K(-82.6%)
$941.00 K(-39.1%)
Jun 2016
-
$253.00 K(+8.1%)
$1.54 M(+19.6%)
Mar 2016
-
$234.00 K(-42.9%)
$1.29 M(+22.1%)
Dec 2015
$1.06 M(-87.0%)
$410.00 K(-36.6%)
$1.06 M(+63.4%)
Sep 2015
-
$647.00 K(-92.0%)
$647.00 K(-92.0%)
Dec 2009
$8.13 M(>+9900.0%)
-
-
Mar 2009
-
$8.13 M(>+9900.0%)
$8.13 M(>+9900.0%)
Jun 2001
-
$1000.00(0.0%)
$3000.00(0.0%)
Mar 2001
-
$1000.00
$3000.00
DateAnnualQuarterlyTTM
Dec 2000
$1000.00(-100.0%)
-
-
Sep 2000
-
$1000.00(0.0%)
-$7000.00(-100.4%)
Jun 2000
-
$1000.00(0.0%)
$1.59 M(-48.5%)
Mar 2000
-
$1000.00(-110.0%)
$3.09 M(-35.5%)
Dec 1999
$4.69 M(-45.5%)
-$10.00 K(-100.6%)
$4.79 M(-35.3%)
Sep 1999
-
$1.60 M(+6.7%)
$7.40 M(-2.6%)
Jun 1999
-
$1.50 M(-11.8%)
$7.60 M(-9.5%)
Mar 1999
-
$1.70 M(-34.6%)
$8.40 M(-2.3%)
Dec 1998
$8.60 M(-13.1%)
$2.60 M(+44.4%)
$8.60 M(-5.5%)
Sep 1998
-
$1.80 M(-21.7%)
$9.10 M(-5.2%)
Jun 1998
-
$2.30 M(+21.1%)
$9.60 M(+2.1%)
Mar 1998
-
$1.90 M(-38.7%)
$9.40 M(-5.1%)
Dec 1997
$9.90 M(+147.5%)
$3.10 M(+34.8%)
$9.90 M(-7.5%)
Sep 1997
-
$2.30 M(+9.5%)
$10.70 M(+25.9%)
Jun 1997
-
$2.10 M(-12.5%)
$8.50 M(+30.8%)
Mar 1997
-
$2.40 M(-38.5%)
$6.50 M(+54.8%)
Dec 1996
$4.00 M(+33.3%)
$3.90 M(+3800.0%)
$4.20 M(+1300.0%)
Sep 1996
-
$100.00 K(0.0%)
$300.00 K(-90.6%)
Jun 1996
-
$100.00 K(0.0%)
$3.20 M(0.0%)
Mar 1996
-
$100.00 K(-96.7%)
$3.20 M(-13.5%)
Dec 1995
$3.00 M(+400.0%)
-
-
Sep 1995
-
$3.00 M(+2900.0%)
$3.70 M(+362.5%)
Jun 1995
-
$100.00 K(0.0%)
$800.00 K(0.0%)
Mar 1995
-
$100.00 K(-80.0%)
$800.00 K(0.0%)
Dec 1994
$600.00 K
$500.00 K(+400.0%)
$800.00 K(+166.7%)
Sep 1994
-
$100.00 K(0.0%)
$300.00 K(+50.0%)
Jun 1994
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
Mar 1994
-
$100.00 K
$100.00 K

FAQ

  • What is La Jolla Pharmaceutical annual revenue?
  • What is the all time high annual revenue for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical annual revenue year-on-year change?
  • What is La Jolla Pharmaceutical quarterly revenue?
  • What is the all time high quarterly revenue for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical quarterly revenue year-on-year change?
  • What is La Jolla Pharmaceutical TTM revenue?
  • What is the all time high TTM revenue for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical TTM revenue year-on-year change?

What is La Jolla Pharmaceutical annual revenue?

The current annual revenue of LJPC is $75.72 M

What is the all time high annual revenue for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high annual revenue is $75.72 M

What is La Jolla Pharmaceutical annual revenue year-on-year change?

Over the past year, LJPC annual revenue has changed by +$42.30 M (+126.58%)

What is La Jolla Pharmaceutical quarterly revenue?

The current quarterly revenue of LJPC is $10.54 M

What is the all time high quarterly revenue for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high quarterly revenue is $34.14 M

What is La Jolla Pharmaceutical quarterly revenue year-on-year change?

Over the past year, LJPC quarterly revenue has changed by -$5.52 M (-34.35%)

What is La Jolla Pharmaceutical TTM revenue?

The current TTM revenue of LJPC is $46.49 M

What is the all time high TTM revenue for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high TTM revenue is $75.72 M

What is La Jolla Pharmaceutical TTM revenue year-on-year change?

Over the past year, LJPC TTM revenue has changed by -$23.73 M (-33.79%)